Board considers Final Dividend for the FY 2024-25

Corporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹55.01

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.9% vs market

Pharmaceuticals peers, median of 147sector+0.5%-4.1% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 4.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6+0.4-3.9+0.5-4.1

Next day

-3.7+0.7-4.3-0.2-3.4

-4.6+0.7-5.3-0.3-4.2

-4.4+0.5-4.9-0.4-4.0

-7.3+1.0-8.3-0.1-7.2

-6.3+1.5-7.8-0.1-6.2

-5.5+2.8-8.4+0.5-6.0

15d

-9.2-0.7-8.5-2.8-6.4

-7.9+3.7-11.6+0.2-8.1

-12.3+3.0-15.3+1.4-13.8

-10.9-1.4-9.5-4.0-7.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sandu Pharmaceuticals Ltd's Board of Directors, at its meeting held on May 28, 2025, recommended a final dividend of Rs. 0.80 per equity share (8% on the paid-up share capital) for the financial year ended March 31, 2025. The dividend is subject to approval from shareholders at the upcoming Annual General Meeting (AGM). The company has not yet announced the record date, AGM date, or the dividend payment date, and will communicate these in due course. The equity shares have a face value of Rs. 10 each.

Likely market impact

Shareholders as on the record date (to be announced) will be eligible to receive the Rs. 0.80 per share dividend, providing a modest income. The recommendation signals stable profitability and a shareholder-friendly approach, though the actual yield depends on the stock's prevailing market price.